Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Topiramate decreases the salience of motivationally relevant visual cues among smokers with alcohol use disorder

Alcoholism Clinical and Experimental Research(2022)10.1111/acer.14771Source: DataRank Database

Topiramate decreases the salience of motivationally relevant visual cues among smokers with alcohol use disorder is a research paper published in Alcoholism Clinical and Experimental Research (2022). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.92)OA: greenTopics (62)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Yong Cui ORCID,Maher Karam‐Hage ORCID,George Kypriotakis ORCID,Francesco Versace ORCID,Nassima Ait‐Daoud Tiouririne ORCID

Live enrichment

PubMed:35037278 PMC:PMC8920769 OpenAlex:https://openalex.org/W4206779333

National Institutes of Health

Grant: R01DA033289

National Institutes of Health

Grant: P30CA016672

National Institutes of Health

Grant: R01AA019720

National Institutes of Health

Grant: 5R01DA033289-04

Identifying topiramate's therapeutic mechanisms through motivational salience

National Institutes of Health

Grant: 5R01AA019720-05

New Pharmacotherapy for Alcohol and Co-morbid Disorders

National Institutes of Health

Grant: 3P30CA016672-41S4

Cancer Center Support (CORE) Grant

FWCI

0.92

Citation Percentile

0.7%

Citation Trend

2022

2025

2026

greenLicense: Wiley Online Library User Agreement

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8920769

journalhttps://doi.org/10.1111/acer.14771

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35037278

repositoryhttps://escholarship.org/uc/item/6b57h7tm

Fields of Study

Substance Abuse Treatment and OutcomesNeurotransmitter Receptor Influence on BehaviorAlcoholism and Thiamine Deficiency0301 basic medicine03 medical and health sciences0302 clinical medicine

MeSH Terms

SmokersTopiramateAlcohol DrinkingAlcoholismCuesHumans

Keywords

TopiramateCue reactivityCravingPsychologyAlcohol use disorderSalience (neuroscience)AbstinencePlaceboClinical psychologyNaltrexoneAlcoholAudiologyAddictionPsychiatryMedicineInternal medicineNeuroscienceOpioidEvent-related potentialsSmokingMediationLate Positive PotentialAlcohol DrinkingBiological PsychologyClinical Trials and Supportive ActivitiesClinical Sciences150610Basic Behavioral and Social ScienceClinical and health psychologySubstance MisuseAlcohol Use and HealthClinical ResearchBehavioral and Social ScienceTobaccoHumansCancerSmokersBiomedical and Clinical SciencesTobacco Smoke and HealthPreventionNeurosciencesSubstance AbusePharmacology and Pharmaceutical SciencesBrain DisordersAlcoholismGood Health and Well Being6.1 PharmaceuticalsCuesDrug Abuse (NIDA only)

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being